APO Research
Talk to an analyst

APO RESEARCH · REPORT

Urea Cycle Disorder (UCD) Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Urea Cycle Disorder (UCD) Drugs Industry Growth and Trends Forecast to 2032

28 December 202594 pages

Choose your research edition.

Industry ResearchUrea Cycle Disorder (UCD) Drugs Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Urea Cycle Disorder (UCD) Drugs Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Urea Cycle Disorder (UCD) Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Urea Cycle Disorder (UCD) Drugs Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Urea Cycle Disorder (UCD) Drugs Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Urea Cycle Disorder (UCD) Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Urea Cycle Disorder (UCD) Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Urea Cycle Disorder (UCD) Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Urea Cycle Disorder (UCD) Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Urea Cycle Disorder (UCD) Drugs include Zhaoke Pharmaceutical, Weijian Pharmaceutical, Recordati Rare Diseases, Kyowa Hakko Bio, Immedica Pharma and Horizon Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Urea Cycle Disorder (UCD) Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Urea Cycle Disorder (UCD) Drugs market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Urea Cycle Disorder (UCD) Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Urea Cycle Disorder (UCD) Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Urea Cycle Disorder (UCD) Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Urea Cycle Disorder (UCD) Drugs Market by Company

Zhaoke Pharmaceutical

Weijian Pharmaceutical

Recordati Rare Diseases

Kyowa Hakko Bio

Immedica Pharma

Horizon Pharma

Urea Cycle Disorder (UCD) Drugs Segment by Type

Glycerol Phenylbutyrate

Sodium Phenylbutyrate

Sodium Benzoate

Other

Urea Cycle Disorder (UCD) Drugs Segment by Application

Hospital

Clinic

Other

Urea Cycle Disorder (UCD) Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Urea Cycle Disorder (UCD) Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Urea Cycle Disorder (UCD) Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Urea Cycle Disorder (UCD) Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Urea Cycle Disorder (UCD) Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Urea Cycle Disorder (UCD) Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Glycerol Phenylbutyrate Table 2. Major Company of Sodium Phenylbutyrate Table 3. Major Company of Sodium Benzoate Table 4. Major Company of Other Table 5. Global Urea Cycle Disorder (UCD) Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Urea Cycle Disorder (UCD) Drugs Sales by Type (2021-2026) & (K Units) Table 7. Global Urea Cycle Disorder (UCD) Drugs Sales Market Share in Volume by Type (2021-2026) Table 8. Global Urea Cycle Disorder (UCD) Drugs Sales by Type (2021-2026) & (US$ Million) Table 9. Global Urea Cycle Disorder (UCD) Drugs Sales Market Share in Value by Type (2021-2026) Table 10. Global Urea Cycle Disorder (UCD) Drugs Price by Type (2021-2026) & (US$/Unit) Table 11. Global Urea Cycle Disorder (UCD) Drugs Sales by Type (2027-2032) & (K Units) Table 12. Global Urea Cycle Disorder (UCD) Drugs Sales Market Share in Volume by Type (2027-2032) Table 13. Global Urea Cycle Disorder (UCD) Drugs Sales by Type (2027-2032) & (US$ Million) Table 14. Global Urea Cycle Disorder (UCD) Drugs Sales Market Share in Value by Type (2027-2032) Table 15. Global Urea Cycle Disorder (UCD) Drugs Price by Type (2027-2032) & (US$/Unit) Table 16. North America Urea Cycle Disorder (UCD) Drugs Sales by Type (2021-2026) & (K Units) Table 17. North America Urea Cycle Disorder (UCD) Drugs Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Urea Cycle Disorder (UCD) Drugs Sales by Type (2021-2026) & (K Units) Table 19. Europe Urea Cycle Disorder (UCD) Drugs Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Urea Cycle Disorder (UCD) Drugs Sales by Type (2021-2026) & (K Units) Table 21. Asia-Pacific Urea Cycle Disorder (UCD) Drugs Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Urea Cycle Disorder (UCD) Drugs Sales by Type (2021-2026) & (K Units) Table 23. Latin America Urea Cycle Disorder (UCD) Drugs Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Urea Cycle Disorder (UCD) Drugs Sales by Type (2021-2026) & (K Units) Table 25. Middle East and Africa Urea Cycle Disorder (UCD) Drugs Sales by Type (2021-2026) & (US$ Million) Table 26. Urea Cycle Disorder (UCD) Drugs Industry Trends Table 27. Urea Cycle Disorder (UCD) Drugs Industry Drivers Table 28. Urea Cycle Disorder (UCD) Drugs Industry Opportunities and Challenges Table 29. Urea Cycle Disorder (UCD) Drugs Industry Restraints Table 30. Global Urea Cycle Disorder (UCD) Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Urea Cycle Disorder (UCD) Drugs Revenue Market Share by Company (2021-2026) Table 32. Global Urea Cycle Disorder (UCD) Drugs Sales by Company (2021-2026) & (K Units) Table 33. Global Urea Cycle Disorder (UCD) Drugs Sales Share by Company (2021-2026) Table 34. Global Urea Cycle Disorder (UCD) Drugs Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Urea Cycle Disorder (UCD) Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Urea Cycle Disorder (UCD) Drugs Major Company Production Sites and Headquarters Table 37. Global Urea Cycle Disorder (UCD) Drugs Company, Product Type & Application Table 38. Global Urea Cycle Disorder (UCD) Drugs Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Urea Cycle Disorder (UCD) Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Urea Cycle Disorder (UCD) Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Urea Cycle Disorder (UCD) Drugs Sales by Region (2021-2026) & (K Units) Table 43. Global Urea Cycle Disorder (UCD) Drugs Sales Market Share in Volume by Region (2021-2026) Table 44. Global Urea Cycle Disorder (UCD) Drugs Sales by Region (2021-2026) & (US$ Million) Table 45. Global Urea Cycle Disorder (UCD) Drugs Sales Market Share in Value by Region (2021-2026) Table 46. Global Urea Cycle Disorder (UCD) Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Urea Cycle Disorder (UCD) Drugs Sales by Region (2027-2032) & (K Units) Table 48. Global Urea Cycle Disorder (UCD) Drugs Sales Market Share in Volume by Region (2027-2032) Table 49. Global Urea Cycle Disorder (UCD) Drugs Sales by Region (2027-2032) & (US$ Million) Table 50. Global Urea Cycle Disorder (UCD) Drugs Sales Market Share in Value by Region (2027-2032) Table 51. Global Urea Cycle Disorder (UCD) Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Urea Cycle Disorder (UCD) Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Urea Cycle Disorder (UCD) Drugs Sales by Application (2021-2026) & (K Units) Table 54. Global Urea Cycle Disorder (UCD) Drugs Sales Market Share in Volume by Application (2021-2026) Table 55. Global Urea Cycle Disorder (UCD) Drugs Sales by Application (2021-2026) & (US$ Million) Table 56. Global Urea Cycle Disorder (UCD) Drugs Sales Market Share in Value by Application (2021-2026) Table 57. Global Urea Cycle Disorder (UCD) Drugs Price by Application (2021-2026) & (US$/Unit) Table 58. Global Urea Cycle Disorder (UCD) Drugs Sales by Application (2027-2032) & (K Units) Table 59. Global Urea Cycle Disorder (UCD) Drugs Sales Market Share in Volume by Application (2027-2032) Table 60. Global Urea Cycle Disorder (UCD) Drugs Sales by Application (2027-2032) & (US$ Million) Table 61. Global Urea Cycle Disorder (UCD) Drugs Sales Market Share in Value by Application (2027-2032) Table 62. Global Urea Cycle Disorder (UCD) Drugs Price by Application (2027-2032) & (US$/Unit) Table 63. North America Urea Cycle Disorder (UCD) Drugs Sales by Application (2021-2026) & (K Units) Table 64. North America Urea Cycle Disorder (UCD) Drugs Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Urea Cycle Disorder (UCD) Drugs Sales by Application (2021-2026) & (K Units) Table 66. Europe Urea Cycle Disorder (UCD) Drugs Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Urea Cycle Disorder (UCD) Drugs Sales by Application (2021-2026) & (K Units) Table 68. Asia-Pacific Urea Cycle Disorder (UCD) Drugs Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Urea Cycle Disorder (UCD) Drugs Sales by Application (2021-2026) & (K Units) Table 70. Latin America Urea Cycle Disorder (UCD) Drugs Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Urea Cycle Disorder (UCD) Drugs Sales by Application (2021-2026) & (K Units) Table 72. Middle East and Africa Urea Cycle Disorder (UCD) Drugs Sales by Application (2021-2026) & (US$ Million) Table 73. Zhaoke Pharmaceutical Company Information Table 74. Zhaoke Pharmaceutical Business Overview Table 75. Zhaoke Pharmaceutical Urea Cycle Disorder (UCD) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Zhaoke Pharmaceutical Urea Cycle Disorder (UCD) Drugs Product Portfolio Table 77. Zhaoke Pharmaceutical Recent Development Table 78. Weijian Pharmaceutical Company Information Table 79. Weijian Pharmaceutical Business Overview Table 80. Weijian Pharmaceutical Urea Cycle Disorder (UCD) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Weijian Pharmaceutical Urea Cycle Disorder (UCD) Drugs Product Portfolio Table 82. Weijian Pharmaceutical Recent Development Table 83. Recordati Rare Diseases Company Information Table 84. Recordati Rare Diseases Business Overview Table 85. Recordati Rare Diseases Urea Cycle Disorder (UCD) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Recordati Rare Diseases Urea Cycle Disorder (UCD) Drugs Product Portfolio Table 87. Recordati Rare Diseases Recent Development Table 88. Kyowa Hakko Bio Company Information Table 89. Kyowa Hakko Bio Business Overview Table 90. Kyowa Hakko Bio Urea Cycle Disorder (UCD) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Kyowa Hakko Bio Urea Cycle Disorder (UCD) Drugs Product Portfolio Table 92. Kyowa Hakko Bio Recent Development Table 93. Immedica Pharma Company Information Table 94. Immedica Pharma Business Overview Table 95. Immedica Pharma Urea Cycle Disorder (UCD) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Immedica Pharma Urea Cycle Disorder (UCD) Drugs Product Portfolio Table 97. Immedica Pharma Recent Development Table 98. Horizon Pharma Company Information Table 99. Horizon Pharma Business Overview Table 100. Horizon Pharma Urea Cycle Disorder (UCD) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Horizon Pharma Urea Cycle Disorder (UCD) Drugs Product Portfolio Table 102. Horizon Pharma Recent Development Table 103. North America Urea Cycle Disorder (UCD) Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 104. North America Urea Cycle Disorder (UCD) Drugs Sales by Country (2021-2026) & (K Units) Table 105. North America Urea Cycle Disorder (UCD) Drugs Sales Market Share by Country (2021-2026) Table 106. North America Urea Cycle Disorder (UCD) Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 107. North America Urea Cycle Disorder (UCD) Drugs Sales Market Share Forecast by Country (2027-2032) Table 108. North America Urea Cycle Disorder (UCD) Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. North America Urea Cycle Disorder (UCD) Drugs Market Size by Country (2021-2026) & (US$ Million) Table 110. North America Urea Cycle Disorder (UCD) Drugs Market Share by Country (2021-2026) Table 111. North America Urea Cycle Disorder (UCD) Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. North America Urea Cycle Disorder (UCD) Drugs Market Share Forecast by Country (2027-2032) Table 113. Europe Urea Cycle Disorder (UCD) Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 114. Europe Urea Cycle Disorder (UCD) Drugs Sales by Country (2021-2026) & (K Units) Table 115. Europe Urea Cycle Disorder (UCD) Drugs Sales Market Share by Country (2021-2026) Table 116. Europe Urea Cycle Disorder (UCD) Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 117. Europe Urea Cycle Disorder (UCD) Drugs Sales Market Share Forecast by Country (2027-2032) Table 118. Europe Urea Cycle Disorder (UCD) Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Europe Urea Cycle Disorder (UCD) Drugs Market Size by Country (2021-2026) & (US$ Million) Table 120. Europe Urea Cycle Disorder (UCD) Drugs Market Share by Country (2021-2026) Table 121. Europe Urea Cycle Disorder (UCD) Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Europe Urea Cycle Disorder (UCD) Drugs Market Share Forecast by Country (2027-2032) Table 123. Asia-Pacific Urea Cycle Disorder (UCD) Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 124. Asia-Pacific Urea Cycle Disorder (UCD) Drugs Sales by Country (2021-2026) & (K Units) Table 125. Asia-Pacific Urea Cycle Disorder (UCD) Drugs Sales Market Share by Country (2021-2026) Table 126. Asia-Pacific Urea Cycle Disorder (UCD) Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 127. Asia-Pacific Urea Cycle Disorder (UCD) Drugs Sales Market Share Forecast by Country (2027-2032) Table 128. Asia-Pacific Urea Cycle Disorder (UCD) Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Asia-Pacific Urea Cycle Disorder (UCD) Drugs Market Size by Country (2021-2026) & (US$ Million) Table 130. Asia-Pacific Urea Cycle Disorder (UCD) Drugs Market Share by Country (2021-2026) Table 131. Asia-Pacific Urea Cycle Disorder (UCD) Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Asia-Pacific Urea Cycle Disorder (UCD) Drugs Market Share Forecast by Country (2027-2032) Table 133. Latin America Urea Cycle Disorder (UCD) Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 134. Latin America Urea Cycle Disorder (UCD) Drugs Sales by Country (2021-2026) & (K Units) Table 135. Latin America Urea Cycle Disorder (UCD) Drugs Sales Market Share by Country (2021-2026) Table 136. Latin America Urea Cycle Disorder (UCD) Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 137. Latin America Urea Cycle Disorder (UCD) Drugs Sales Market Share Forecast by Country (2027-2032) Table 138. Latin America Urea Cycle Disorder (UCD) Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Latin America Urea Cycle Disorder (UCD) Drugs Market Size by Country (2021-2026) & (US$ Million) Table 140. Latin America Urea Cycle Disorder (UCD) Drugs Market Share by Country (2021-2026) Table 141. Latin America Urea Cycle Disorder (UCD) Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Latin America Urea Cycle Disorder (UCD) Drugs Market Share Forecast by Country (2027-2032) Table 143. Middle East and Africa Urea Cycle Disorder (UCD) Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 144. Middle East and Africa Urea Cycle Disorder (UCD) Drugs Sales by Country (2021-2026) & (K Units) Table 145. Middle East and Africa Urea Cycle Disorder (UCD) Drugs Sales Market Share by Country (2021-2026) Table 146. Middle East and Africa Urea Cycle Disorder (UCD) Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 147. Middle East and Africa Urea Cycle Disorder (UCD) Drugs Sales Market Share Forecast by Country (2027-2032) Table 148. Middle East and Africa Urea Cycle Disorder (UCD) Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Middle East and Africa Urea Cycle Disorder (UCD) Drugs Market Size by Country (2021-2026) & (US$ Million) Table 150. Middle East and Africa Urea Cycle Disorder (UCD) Drugs Market Share by Country (2021-2026) Table 151. Middle East and Africa Urea Cycle Disorder (UCD) Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Middle East and Africa Urea Cycle Disorder (UCD) Drugs Market Share Forecast by Country (2027-2032) Table 153. Key Raw Materials Table 154. Raw Materials Key Suppliers Table 155. Urea Cycle Disorder (UCD) Drugs Distributors List Table 156. Urea Cycle Disorder (UCD) Drugs Customers List Table 157. Research Programs/Design for This Report Table 158. Authors List of This Report Table 159. Secondary Sources Table 160. Primary Sources List of Figures Figure 1. Urea Cycle Disorder (UCD) Drugs Image Figure 2. Global Urea Cycle Disorder (UCD) Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Urea Cycle Disorder (UCD) Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Urea Cycle Disorder (UCD) Drugs Sales (2021-2032) & (K Units) Figure 5. Glycerol Phenylbutyrate Image Figure 6. Global Glycerol Phenylbutyrate Sales YoY Growth (2021-2032) & (K Units) Figure 7. Sodium Phenylbutyrate Image Figure 8. Global Sodium Phenylbutyrate Sales YoY Growth (2021-2032) & (K Units) Figure 9. Sodium Benzoate Image Figure 10. Global Sodium Benzoate Sales YoY Growth (2021-2032) & (K Units) Figure 11. Other Image Figure 12. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 13. Global Urea Cycle Disorder (UCD) Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Urea Cycle Disorder (UCD) Drugs Market Share by Type 2025 VS 2032 Figure 15. North America Urea Cycle Disorder (UCD) Drugs Sales Market Share in Volume by Type in 2025 Figure 16. North America Urea Cycle Disorder (UCD) Drugs Sales Market Share in Value by Type in 2025 Figure 17. Europe Urea Cycle Disorder (UCD) Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Europe Urea Cycle Disorder (UCD) Drugs Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Urea Cycle Disorder (UCD) Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Urea Cycle Disorder (UCD) Drugs Sales Market Share in Value by Type in 2025 Figure 21. Latin America Urea Cycle Disorder (UCD) Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Urea Cycle Disorder (UCD) Drugs Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Urea Cycle Disorder (UCD) Drugs Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Urea Cycle Disorder (UCD) Drugs Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Urea Cycle Disorder (UCD) Drugs Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Hospital Image Figure 28. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 29. Clinic Image Figure 30. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 31. Other Image Figure 32. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global Urea Cycle Disorder (UCD) Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Urea Cycle Disorder (UCD) Drugs Market Share by Application 2025 VS 2032 Figure 35. North America Urea Cycle Disorder (UCD) Drugs Sales Market Share in Volume by Application in 2025 Figure 36. North America Urea Cycle Disorder (UCD) Drugs Sales Market Share in Value by Application in 2025 Figure 37. Europe Urea Cycle Disorder (UCD) Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Europe Urea Cycle Disorder (UCD) Drugs Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Urea Cycle Disorder (UCD) Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Urea Cycle Disorder (UCD) Drugs Sales Market Share in Value by Application in 2025 Figure 41. Latin America Urea Cycle Disorder (UCD) Drugs Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Urea Cycle Disorder (UCD) Drugs Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Urea Cycle Disorder (UCD) Drugs Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Urea Cycle Disorder (UCD) Drugs Sales Market Share in Value by Application in 2025 Figure 45. North America Urea Cycle Disorder (UCD) Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America Urea Cycle Disorder (UCD) Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Urea Cycle Disorder (UCD) Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Urea Cycle Disorder (UCD) Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Urea Cycle Disorder (UCD) Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe Urea Cycle Disorder (UCD) Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Urea Cycle Disorder (UCD) Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Urea Cycle Disorder (UCD) Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Urea Cycle Disorder (UCD) Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific Urea Cycle Disorder (UCD) Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Urea Cycle Disorder (UCD) Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Urea Cycle Disorder (UCD) Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Urea Cycle Disorder (UCD) Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America Urea Cycle Disorder (UCD) Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Urea Cycle Disorder (UCD) Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Urea Cycle Disorder (UCD) Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Urea Cycle Disorder (UCD) Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa Urea Cycle Disorder (UCD) Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Urea Cycle Disorder (UCD) Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Urea Cycle Disorder (UCD) Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Urea Cycle Disorder (UCD) Drugs Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Urea Cycle Disorder (UCD) Drugs Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Glycerol Phenylbutyrate
  • Sodium Phenylbutyrate
  • Sodium Benzoate
  • Other
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Zhaoke Pharmaceutical
  • Weijian Pharmaceutical
  • Recordati Rare Diseases
  • Kyowa Hakko Bio
  • Immedica Pharma
  • Horizon Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Urea Cycle Disorder (UCD) Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Urea Cycle Disorder (UCD) Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Urea Cycle Disorder (UCD) Drugs Market by Type
  6. 1.3.1 Glycerol Phenylbutyrate
  7. 1.3.2 Sodium Phenylbutyrate
  8. 1.3.3 Sodium Benzoate
  9. 1.3.4 Other
  10. 1.4 Global Urea Cycle Disorder (UCD) Drugs Market Size by Type
  11. 1.4.1 Global Urea Cycle Disorder (UCD) Drugs Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Urea Cycle Disorder (UCD) Drugs Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Urea Cycle Disorder (UCD) Drugs Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Urea Cycle Disorder (UCD) Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Urea Cycle Disorder (UCD) Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Urea Cycle Disorder (UCD) Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Urea Cycle Disorder (UCD) Drugs Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Urea Cycle Disorder (UCD) Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Urea Cycle Disorder (UCD) Drugs Industry Trends
  2. 2.2 Urea Cycle Disorder (UCD) Drugs Industry Drivers
  3. 2.3 Urea Cycle Disorder (UCD) Drugs Industry Opportunities and Challenges
  4. 2.4 Urea Cycle Disorder (UCD) Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Urea Cycle Disorder (UCD) Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Urea Cycle Disorder (UCD) Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Urea Cycle Disorder (UCD) Drugs Price (2021-2026)
  4. 3.4 Global Urea Cycle Disorder (UCD) Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Urea Cycle Disorder (UCD) Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Urea Cycle Disorder (UCD) Drugs Company, Product Type & Application
  7. 3.7 Global Urea Cycle Disorder (UCD) Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Urea Cycle Disorder (UCD) Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Urea Cycle Disorder (UCD) Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Urea Cycle Disorder (UCD) Drugs Tier 1, Tier 2, and Tier 3
4 Urea Cycle Disorder (UCD) Drugs Regional Status and Outlook
  1. 4.1 Global Urea Cycle Disorder (UCD) Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Urea Cycle Disorder (UCD) Drugs Historic Market Size by Region
  3. 4.2.1 Global Urea Cycle Disorder (UCD) Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Urea Cycle Disorder (UCD) Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Urea Cycle Disorder (UCD) Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Urea Cycle Disorder (UCD) Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Urea Cycle Disorder (UCD) Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Urea Cycle Disorder (UCD) Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Urea Cycle Disorder (UCD) Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Urea Cycle Disorder (UCD) Drugs by Application
  1. 5.1 Urea Cycle Disorder (UCD) Drugs Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Urea Cycle Disorder (UCD) Drugs Market Size by Application
  6. 5.2.1 Global Urea Cycle Disorder (UCD) Drugs Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Urea Cycle Disorder (UCD) Drugs Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Urea Cycle Disorder (UCD) Drugs Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Urea Cycle Disorder (UCD) Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Urea Cycle Disorder (UCD) Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Urea Cycle Disorder (UCD) Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Urea Cycle Disorder (UCD) Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Urea Cycle Disorder (UCD) Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Zhaoke Pharmaceutical
  2. 6.1.1 Zhaoke Pharmaceutical Company Information
  3. 6.1.2 Zhaoke Pharmaceutical Business Overview
  4. 6.1.3 Zhaoke Pharmaceutical Urea Cycle Disorder (UCD) Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Zhaoke Pharmaceutical Urea Cycle Disorder (UCD) Drugs Product Portfolio
  6. 6.1.5 Zhaoke Pharmaceutical Recent Developments
  7. 6.2 Weijian Pharmaceutical
  8. 6.2.1 Weijian Pharmaceutical Company Information
  9. 6.2.2 Weijian Pharmaceutical Business Overview
  10. 6.2.3 Weijian Pharmaceutical Urea Cycle Disorder (UCD) Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Weijian Pharmaceutical Urea Cycle Disorder (UCD) Drugs Product Portfolio
  12. 6.2.5 Weijian Pharmaceutical Recent Developments
  13. 6.3 Recordati Rare Diseases
  14. 6.3.1 Recordati Rare Diseases Company Information
  15. 6.3.2 Recordati Rare Diseases Business Overview
  16. 6.3.3 Recordati Rare Diseases Urea Cycle Disorder (UCD) Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Recordati Rare Diseases Urea Cycle Disorder (UCD) Drugs Product Portfolio
  18. 6.3.5 Recordati Rare Diseases Recent Developments
  19. 6.4 Kyowa Hakko Bio
  20. 6.4.1 Kyowa Hakko Bio Company Information
  21. 6.4.2 Kyowa Hakko Bio Business Overview
  22. 6.4.3 Kyowa Hakko Bio Urea Cycle Disorder (UCD) Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Kyowa Hakko Bio Urea Cycle Disorder (UCD) Drugs Product Portfolio
  24. 6.4.5 Kyowa Hakko Bio Recent Developments
  25. 6.5 Immedica Pharma
  26. 6.5.1 Immedica Pharma Company Information
  27. 6.5.2 Immedica Pharma Business Overview
  28. 6.5.3 Immedica Pharma Urea Cycle Disorder (UCD) Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Immedica Pharma Urea Cycle Disorder (UCD) Drugs Product Portfolio
  30. 6.5.5 Immedica Pharma Recent Developments
  31. 6.6 Horizon Pharma
  32. 6.6.1 Horizon Pharma Company Information
  33. 6.6.2 Horizon Pharma Business Overview
  34. 6.6.3 Horizon Pharma Urea Cycle Disorder (UCD) Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Horizon Pharma Urea Cycle Disorder (UCD) Drugs Product Portfolio
  36. 6.6.5 Horizon Pharma Recent Developments
7 North America by Country
  1. 7.1 North America Urea Cycle Disorder (UCD) Drugs Sales by Country
  2. 7.1.1 North America Urea Cycle Disorder (UCD) Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Urea Cycle Disorder (UCD) Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Urea Cycle Disorder (UCD) Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Urea Cycle Disorder (UCD) Drugs Market Size by Country
  6. 7.2.1 North America Urea Cycle Disorder (UCD) Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Urea Cycle Disorder (UCD) Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Urea Cycle Disorder (UCD) Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Urea Cycle Disorder (UCD) Drugs Sales by Country
  2. 8.1.1 Europe Urea Cycle Disorder (UCD) Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Urea Cycle Disorder (UCD) Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Urea Cycle Disorder (UCD) Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Urea Cycle Disorder (UCD) Drugs Market Size by Country
  6. 8.2.1 Europe Urea Cycle Disorder (UCD) Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Urea Cycle Disorder (UCD) Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Urea Cycle Disorder (UCD) Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Urea Cycle Disorder (UCD) Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Urea Cycle Disorder (UCD) Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Urea Cycle Disorder (UCD) Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Urea Cycle Disorder (UCD) Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Urea Cycle Disorder (UCD) Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Urea Cycle Disorder (UCD) Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Urea Cycle Disorder (UCD) Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Urea Cycle Disorder (UCD) Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Urea Cycle Disorder (UCD) Drugs Sales by Country
  2. 10.1.1 South America Urea Cycle Disorder (UCD) Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Urea Cycle Disorder (UCD) Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Urea Cycle Disorder (UCD) Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Urea Cycle Disorder (UCD) Drugs Market Size by Country
  6. 10.2.1 South America Urea Cycle Disorder (UCD) Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Urea Cycle Disorder (UCD) Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Urea Cycle Disorder (UCD) Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Urea Cycle Disorder (UCD) Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Urea Cycle Disorder (UCD) Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Urea Cycle Disorder (UCD) Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Urea Cycle Disorder (UCD) Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Urea Cycle Disorder (UCD) Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Urea Cycle Disorder (UCD) Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Urea Cycle Disorder (UCD) Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Urea Cycle Disorder (UCD) Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Urea Cycle Disorder (UCD) Drugs Value Chain Analysis
  2. 12.1.1 Urea Cycle Disorder (UCD) Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Urea Cycle Disorder (UCD) Drugs Production Mode & Process
  7. 12.2 Urea Cycle Disorder (UCD) Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Urea Cycle Disorder (UCD) Drugs Distributors
  10. 12.2.3 Urea Cycle Disorder (UCD) Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst